FDA
-
-
-
-
-
-
-
FDA approves Genentech's Tecentriq for bladder cancer treatment
-
-
-
-
-
-
-
Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients
-
-
-
-
-
-
-
Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection
-
-
-
-
-
-
-
Natera Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
New KDIGO Guideline Supports Genetic Testing for the Majority of CKD Patients to Establish Cause of Disease
-
-
-
-
-
-
-
Natera’s Landmark RenaCARE Study Demonstrates Significant Diagnostic and Clinical Utility of Renasight™ in Chronic Kidney Disease
-
-
-
-
-
-
-
Natera's (NTRA) Prospera Lung Transplant Assessment Test Granted Medicare Coverage
-
322,206 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

